Pricing Of Prescription Drugs


Pricing Of Prescription Drugs
DOWNLOAD
FREE 30 Days

Download Pricing Of Prescription Drugs PDF/ePub or read online books in Mobi eBooks. Click Download or Read Online button to get Pricing Of Prescription Drugs book now. This website allows unlimited access to, at the time of writing, more than 1.5 million titles, including hundreds of thousands of titles in various foreign languages. If the content not found or just blank you must refresh this page





The Right Price


The Right Price
DOWNLOAD
FREE 30 Days

Author : Peter J. Neumann
language : en
Publisher: Oxford University Press
Release Date : 2021

The Right Price written by Peter J. Neumann and has been published by Oxford University Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2021 with Business & Economics categories.


The prescription drug market -- Proposed solutions for rising drug prices -- Measuring the value of prescription drugs -- Measuring drug value : whose job is it anyway? -- Institute for Clinical and Economic Review (ICER) -- Other US value assessment frameworks -- Do drugs for special populations warrant higher prices? -- Improving value measurement -- Aligning prices with value -- The path forward.



Prescription Drug Pricing Background Discount Programs And Cost Lowering Strategies


Prescription Drug Pricing Background Discount Programs And Cost Lowering Strategies
DOWNLOAD
FREE 30 Days

Author : Elias B. Toft
language : en
Publisher: Nova Snova
Release Date : 2020-03-13

Prescription Drug Pricing Background Discount Programs And Cost Lowering Strategies written by Elias B. Toft and has been published by Nova Snova this book supported file pdf, txt, epub, kindle and other format this book has been release on 2020-03-13 with categories.


Chapter 1 examines the actions of drug companies in raising prescription drug prices in the United States, as well as the effects of these actions on the Federal and state budgets, and on American families. Chapter 2 addresses frequently asked questions about government and private-sector policies that affect drug prices and availability. Among the prescription drug topics covered are federally funded research and development, regulation of direct-to-consumer advertising, legal restrictions on reimportation, and federal price negotiation. The 340B Drug Pricing Program requires drug manufacturers to sell outpatient drugs at discounted prices to covered entitiesâeligible clinics, hospitals, and othersâin order to have their drugs covered by Medicaid. Covered entities are only allowed to provide 340B drugs to certain eligible patients. Chapter 3 reviews the Health Resources and Services Administration's (HRSA) oversight of the 340B Program to ensure compliance with program rules. In 2017, nearly 60% of U.S. adults aged 18â64 reported being prescribed medication in the past 12 months. Approximately 70% of prescription medications carry out-of-pocket costs. Strategies to reduce prescription drug costs at the individual level are discussed in chapters 4 and 5. Each year, Americans pay more for prescription drugs, and rising drug prices have a disproportionate impact on older Americans. Chapter 6 examines the history of rising drug prices for the brand-name drugs most commonly prescribed for seniors. Generic drugsâcopies of brand-name drugsâlead to significant cost savings. Before a generic drug can be marketed, FDA must approve the generic drug application. According to FDA, applications go through an average of three cycles of review before being approved, which may take years. Chapter 7 examines 1) the first review cycle approval rate of generic drug applications in recent years and factors that may have contributed to whether applications were approved; and 2) changes FDA has made to increase the first review cycle approval rate.



Prescription Drug Pricing


Prescription Drug Pricing
DOWNLOAD
FREE 30 Days

Author : Jonathan R. Dickson
language : en
Publisher:
Release Date : 2011

Prescription Drug Pricing written by Jonathan R. Dickson and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2011 with Medical economics categories.


The growing cost of brand-name prescription drugs can be a burden on patients, payers and providers of health care, particularly when price increases are large and occur suddenly. Controlling rising prescription drug prices helps to ensure that patients can afford medically necessary and sometimes life-saving medication, and to moderate costs for hospitals and third-party payers such as insurance plans and state and federal governments. This book examines prescription drug pricing costs and control concerns with a focus on extraordinary price increases for brand-name prescription drugs, as well as the characteristics and factors that contributed to this price increase.



Powerful Medicines


Powerful Medicines
DOWNLOAD
FREE 30 Days

Author : Jerry Avorn, M.D.
language : en
Publisher: Vintage
Release Date : 2008-12-10

Powerful Medicines written by Jerry Avorn, M.D. and has been published by Vintage this book supported file pdf, txt, epub, kindle and other format this book has been release on 2008-12-10 with Medical categories.


If you believe that the latest blockbuster medication is worth a premium price over your generic brand, or that doctors have access to all the information they need about a drug’s safety and effectiveness each time they write a prescription, Dr. Jerry Avorn has some sobering news. Drawing on more than twenty-five years of patient care, teaching, and research at Harvard Medical School, he shares his firsthand experience of the wide gap in our knowledge of the effectiveness of one medication as compared to another. In Powerful Medicines, he reminds us that every pill we take represents a delicate compromise between the promise of healing, the risk of side effects, and an increasingly daunting price. The stakes on each front grow higher every year as new drugs with impressive power, worrisome side effects, and troubling costs are introduced. This is a comprehensive behind-the-scenes look at issues that affect everyone: our shortage of data comparing the worth of similar drugs for the same condition; alarming lapses in the detection of lethal side effects; the underuse of life-saving medications; lavish marketing campaigns that influence what doctors prescribe; and the resulting upward spiral of costs that places vital drugs beyond the reach of many Americans. In this engagingly written book, Dr. Avorn asks questions that will interest every consumer: How can a product judged safe by the Food and Drug Administration turn out to have unexpectedly lethal side effects? Why has the nation’s drug bill been growing at nearly 20 percent per year? How can physicians and patients pick the best medication in its class? How do doctors actually make their prescribing decisions, and why do those decisions sometimes go wrong? Why do so many Americans suffer preventable illnesses and deaths that proper drug use could have averted? How can the nation gain control over its escalating drug budget without resorting to rationing or draconian governmental controls? Using clinical case histories taken from his own work as a practitioner, researcher, and advocate, Dr. Avorn demonstrates the impressive power of the well-conceived prescription as well as the debacles that can result when medications are misused. He describes an innovative program that employs the pharmaceutical industry’s own marketing techniques to reduce use of some of the most overprescribed and overpriced products. Powerful Medicines offers timely and practical advice on how the nation can improve its drug-approval process, and how patients can work with doctors to make sure their prescriptions are safe, effective, and as affordable as possible. This is a passionate and provocative call for action as well as a compelling work of clear-headed science.



Making Medicines Affordable


Making Medicines Affordable
DOWNLOAD
FREE 30 Days

Author : National Academies of Sciences, Engineering, and Medicine
language : en
Publisher: National Academies Press
Release Date : 2018-03-01

Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and has been published by National Academies Press this book supported file pdf, txt, epub, kindle and other format this book has been release on 2018-03-01 with Medical categories.


Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.



Comparative Pricing Of Prescription Drugs Sold In The United States And Canada And The Effects On U S Consumers


Comparative Pricing Of Prescription Drugs Sold In The United States And Canada And The Effects On U S Consumers
DOWNLOAD
FREE 30 Days

Author : United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism
language : en
Publisher:
Release Date : 2003

Comparative Pricing Of Prescription Drugs Sold In The United States And Canada And The Effects On U S Consumers written by United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Consumer Affairs, Foreign Commerce, and Tourism and has been published by this book supported file pdf, txt, epub, kindle and other format this book has been release on 2003 with Consumer protection categories.




The Price Of Global Health


The Price Of Global Health
DOWNLOAD
FREE 30 Days

Author : Ed Schoonveld
language : en
Publisher: Routledge
Release Date : 2016-02-24

The Price Of Global Health written by Ed Schoonveld and has been published by Routledge this book supported file pdf, txt, epub, kindle and other format this book has been release on 2016-02-24 with Business & Economics categories.


Public debate on the rising cost of new biotechnology drug treatments has intensified over the last few years as healthcare budget pressures have mounted under a strained economy. Meanwhile, the demand for new, effective medical and drug treatments continues to rise as unhealthy lifestyles cause further increases in diabetes and cardiovascular disease. Global drug pricing is one of the most hotly debated yet least understood aspects of the pharmaceutical industry. How should drug prices be set and what does it mean for patients? Why do governments increasingly get involved, and what is its impact on the global competitive environment? How can a life-saving industry have a poorer image than gun and tobacco industries, whose products are associated with death? Ed Schoonveld explains how pharmaceutical prices are determined in a complex global payer environment and what factors influence the process. His insights will help a wide range of audiences, from healthcare industry professionals to policy makers and the broader public, to gain a better understanding of this highly complex and emotionally charged field. The Price of Global Health is recognized as a valued and unique reference book that covers a complete array of topics related to global pharmaceutical pricing. It contains an in-depth but straightforward exploration of the pharmaceutical pricing strategy process, its underlying market access, general business and ethical considerations, and its implications for payers, physicians and patients. It is a much-needed and invaluable resource for anybody interested or involved in, or affected by, the development, funding and use of prescription drugs. In particular, it is of critical importance to pharmaceutical company executives and other leaders and professionals in commercialization and drug development, including marketing, business development, market access and pricing, clinical development, drug discovery, regulatory affairs, health outcomes, market research and public affairs. The second edition includes new chapters on payer value story development, oncology, orphan drugs and payer negotiations. Furthermore, many country chapters have been substantially updated to reflect changes in the healthcare systems, including the Affordable Care Act in the US, AMNOG in Germany, medico-economic requirements in France and many other country-specific changes. Lastly, almost every chapter has been updated with new examples and illustrations.



Pricing Of Prescription Drugs


Pricing Of Prescription Drugs
DOWNLOAD
FREE 30 Days

Author : Elizabeth R. Nesbitt
language : en
Publisher: DIANE Publishing
Release Date : 2000

Pricing Of Prescription Drugs written by Elizabeth R. Nesbitt and has been published by DIANE Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2000 with Drugs categories.




Prescription Drugs An Overview Of Approaches To Negotiate Drug Prices Used By Other Countries U S Private Payers Federal Programs


Prescription Drugs An Overview Of Approaches To Negotiate Drug Prices Used By Other Countries U S Private Payers Federal Programs
DOWNLOAD
FREE 30 Days

Author :
language : en
Publisher: DIANE Publishing
Release Date :

Prescription Drugs An Overview Of Approaches To Negotiate Drug Prices Used By Other Countries U S Private Payers Federal Programs written by and has been published by DIANE Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on with categories.




Prescription Drugs


Prescription Drugs
DOWNLOAD
FREE 30 Days

Author : John E. Dicken
language : en
Publisher: DIANE Publishing
Release Date : 2011-08

Prescription Drugs written by John E. Dicken and has been published by DIANE Publishing this book supported file pdf, txt, epub, kindle and other format this book has been release on 2011-08 with Medical categories.


Prescription drug spending in the U.S. in 2009 totaled $250 billion, of which $78 billion -- or 31% -- was spent by the fed. gov¿t. Prescription drug spending by the fed. gov¿t., patients, and third-party payers, including employers, is driven by many factors, including the prices paid for drugs. This report: (1) examines U&C price trends for commonly used prescription drugs from 2006 through the first quarter of 2010 and compares these trends to those of other medical consumer goods and services; and (2) examines price trends using drug prices other than U&C. Also provides info. on the extent to which prices for individual brand-name drugs changed over the course of this analysis period. Charts and tables. This is a print on demand report.